Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Nancy McKinney who wrote (1132)	7/20/1998 1:11:00 PM
From: Patricia Trinchero	Read Replies (2) \| Respond to of 4028

Scientists can transfer genetic codes into living cells, but only when they are being grown in vitro ( in a test tube ). What CYGS is working on will allow them to transfer genetic codes in vivo ( in a large organism that is alive, breathing, moving like humans. Their virus will help genetic engineers to target specific body cells. This virus should bring the DNA or RNA into whatever body cell is being targeted. In the case of aging, the virus would have to be altered in a way that would vector it toward that skin and it would hook up inside the cell and deliver it's new code during cell replication.